Your browser doesn't support javascript.
loading
The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.
Schräder, Nicholas H B; Duipmans, José C; Renken, Remco J; Sörös, Peter; Vermeulen, Karin M; Bolling, Maria C; Wolff, André P.
Afiliação
  • Schräder NHB; Department of Dermatology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Duipmans JC; Department of Dermatology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Renken RJ; Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen, The Netherlands.
  • Sörös P; Department of Neurology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
  • Vermeulen KM; Research Center Neurosensory Science, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
  • Bolling MC; Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Wolff AP; Department of Dermatology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
PLoS One ; 17(12): e0277512, 2022.
Article em En | MEDLINE | ID: mdl-36508401
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Epidermólise Bolhosa / Dor Crônica Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Epidermólise Bolhosa / Dor Crônica Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article